A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/122 (2006.01) A61K 31/404 (2006.01) A61K 31/4184 (2006.01) A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61K 31/505 (2006.01) A61K 31/519 (2006.01) A61K 31/5377 (2006.01) A61P 25/00 (2006.01) A61P 25/16 (2006.01) A61P 25/18 (2006.01) A61P 25/28 (2006.01)
Patent
CA 2533074
The invention relates generally to the methods of treating brain diseases and compounds for treating brain diseases, and more specifically relates to using compounds that are able to modulate guanine nucleotide exchange factors for proteins belonging to the Rap family of small GTPases to treat diseases of the brain, such as Alzheimer's and Schizophrenia.
L'invention concerne généralement des procédés de traitement de maladies cérébrales, des composés pour le traitement de maladies cérébrales, et plus spécifiquement l'utilisation de composés pour moduler les facteurs d'échange du nucléotide guanine pour les protéines appartenant à la famille Rap des petites GTPases, pour le traitement de maladies cérébrales, telles que la maladie d'Alzheimer et la schizophrénie.
Breslin Catherine
Cooreman Ann
Donald Gibson Lucien Charles
Hammond Stephen
John Mackenzie Simon
Borden Ladner Gervais Llp
Breslin Catherine
Cooreman Ann
Donald Gibson Lucien Charles
Hammond Stephen
LandOfFree
Regulation of guanine nucleotide exchange factor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Regulation of guanine nucleotide exchange factor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of guanine nucleotide exchange factor will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1398075